Related topics: Industry Drivers
The European Commission’s latest guidelines on the manufacture of medicinal products derived from human blood or plasma has been opened up to public consultation.
Defined in the document are the good manufacturing practice requirements for processing, storage and transport of human plasma that is to be used in medicinal products.
The guidance takes into account the additional risks posed by manufacturing products from human blood or plasma, such as the potential for contamination with disease-transmitting agents.
The complete consultation document can be found here .
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
